News

On February 8, Associate Dean of Educational Quality and Outcomes Lawrence Loo, MD, became the sixth recipient of the Kinzer-Rice Award, which honors faculty who exemplify excellence in teaching at Loma Linda University. The presentation ceremony for the award took place during the Faculty Development Showcase.

The Center for Health Disparities and Molecular Medicine at Loma Linda University School of Medicine was recently awarded more than $2.6 million to fund a program that has vastly increased the number of highly qualified minority students in biomedical doctoral programs.  The award from the National Institute of General Medical Sciences, part of the National Institutes of Health (NIH), will continue supporting the “LLU-NIH Initiative for Maximizing Student Development program” (LLU-NIH IMSD), which was designed to guide underrepresented minority students through their PhD studies and to

By Larry Kidder One of the leading experts in fetal development will give the keynote address at the inaugural Longo Symposium on January 9 at Loma Linda University Medical Center. Peter W. Nathanielsz, MD, PhD, ScD, distinguished research professor in Life Course Studies at the University of Wyoming’s College of Agriculture and Natural Resources, will give his presentation “From Womb to Tomb: The Interaction of Developmental Programming and Aging Mechanisms.”  Nathanielsz is one of eight translational research experts speaking at the symposium, which will be held from 8:30 a.m.

Six faculty at Loma Linda University Health are among the first 204 physicians nationwide to be certified by the American Board of Lifestyle Medicine, making LLUH the largest academic health care provider of lifestyle medicine specialists. The only other organization to also employ six lifestyle medicine specialists is Premise Health for Cummins Inc., manufacturers of diesel and gas engines. With the certification of these physicians, LLUH reaffirms its commitment to be a leader in lifestyle medicine, which treats the underlying cause of chronic disease by changing behaviors like eating

More than a decade ago, Kevin Shannon, MD, MPH, was serving as medical director of Kijabe Hospital in Kijabe, Kenya. He struggled to keep enough staff at the hospital to support the new family medicine residency program, especially around the holidays. “I realized it would have been really nice to have an organization that would be a resource for mission hospitals trying to train national physicians,” Shannon recalled.

When Caden Henderson was admitted to the Loma Linda University Children’s Hospital last year, his mother, Jill, was beside herself. Caden had never been sick enough to need to stay at the hospital before. What was she supposed to do? She grabbed an old teddy bear from their house and brought it to his hospital room. Caden, who was 11 at the time, had outgrown stuffed animals but she thought a small piece of home would be comforting.

By Larry Kidder Half a century ago, Louis Smith, MD, performed the first kidney transplant in the “hospital on the hill”—now Nichol Hall. On Sunday, Nov.

The U.S.

About four out of every 1,000 full-term births and 60 percent of premature infants suffer from hypoxic ischemic encephalopathy, a serious brain injury that results from inadequate oxygen reaching the infant brain. Of these children, 40 to 60 percent will die or suffer from severe disabilities including retardation, epilepsy and cerebral palsy by the time they turn 2 years old. It is a birth complication with no cure and few treatment options.

A new medication to treat symptoms of sickle cell disease, developed following 25 years of research by a Loma Linda University School of Medicine alumnus, has received approval from the U.S. Food and Drug Administration, the first new drug for the condition to receive FDA approval in nearly 20 years. According to Yutaka Niihara, MD, MPH (SM ‘86), the new drug, known as Endari, significantly reduces the symptoms experienced by people with sickle cell disease.